All regulations
Nonrulemaking
FDA
Open for Comments
FDA-2026-P-2305
Request that the FDA determine whether the following applications held by Hospira Inc. have been voluntarily withdrawn or withheld from sale for reasons of safety or efficacy.
Documents
4
Comments
0
Description
Open
Key Dates
Comment Period OpensMar 5, 2026
Documents
| Type | Title | Status |
|---|---|---|
Other |
Keywords
CDER
Citizen Petition
Apotex Inc.
determine whether the
following applications held by Hospira Inc
have been voluntarily withdrawn or withheld
from sale for reasons of safety or efficacy
NDA 018920 M.V.I. Pediatric
Data from Regulations.gov